














Copyright©2021 by Faculty of Medicine Universitas Diponegoro and Indonesian Society of Human Genetics 
 
Case Reports 
Cushing’s syndrome manifesting as chronic insomnia caused by ad-
renal cortical adenoma with incidental pituitary microadenoma 
 
 
  Rizky Rakhmayanti1,6*, Tania Tedjo Minuljo1,6, Herlina Suryawati2,6, Alifiati Fitrikasari3,6, Mohamad Adi 
Soedarso4,6, Dody Priambada5,6 
 
1Internal Medicine Department, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 
2Neurology Department, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 
3Psychiatric Department, Faculty of Medicine Universitas Diponegoro, Semarang, Indonesia 
4Urology Division of Surgery Department, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 
5Neurosurgery Department, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia 





Received: 23 Oct 2020 
Accepted: 16 Apr 2021 
Available: 30 Apr 2021 
Abstract 
Background: Cushing’s syndrome is a condition caused by excessive glucocorticoid 
with insomnia as one of its neuropsychiatric manifestation. Cushing’s syndrome may 
be caused by excessive adrenocorticotropin hormone (ACTH-dependent), for example 
from ACTH producing pituitary tumors, or by overproduction of cortisol by adreno-
cortical tumors. In this report, we presented a case with Cushing’s syndrome manifest-
ing as chronic insomnia with adrenal cortical adenoma and pituitary microadenoma. 
Case presentation: A 30-year-old woman was consulted from the Neurologic Depart-
ment to the Internal Medicine Department with the chief complaint of insomnia and 
worsening headache for 6 months prior to the admission. She had undergone head MRI 
and abdominal CT scan previously and was found to have both pituitary microade-
noma and left adrenal mass. From the physical examination she had clinical signs of 
Cushing’s syndrome like Cushingoid face and purplish striae on her stomach. Mid-
night cortisol serum examination was done initially and showed high level of cortisol. 
High dose dexamethasone suppression test or DST (8 mg overnight) was later per-
formed to help determine the main cause of Cushing’s syndrome. The result failed to 
reach 50% suppression of cortisol serum, suggestive that the Cushing’s syndrome was 
not ACTH-dependent from the pituitary but potentially from overproduction of corti-
sol by the left adrenal mass. Therefore, left adrenalectomy was performed and the his-
topathological study supported the diagnosis of adrenal cortical adenoma. 
Conclusion: Chronic insomnia is a very important symptoms of Cushing’s syndrome 
that should not be neglected. The patient had both microadenoma pituitary and left 
adrenal mass thus high dose DST test (8 mg overnight) needed to be performed to 
differentiate the source of Cushing’s syndrome. The result showed only little suppres-
sion therefore the pituitary microadenoma was not the source of Cushing’s syndrome 
and more suggestive from the adrenal etiology. 
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INTRODUCTION 
 Cushing’s syndrome is described as a condition 
caused by high level of glucocorticoid hormone in the 
blood. The condition may be caused by over secretion of 
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endogenous cortisol by the adrenal gland or administra-
tion of exogenous glucocorticoid agents meant for treat-
ment of certain diseases1. Endogenous hypercortisolism 
can be further classified into ACTH-dependent Cush-
ing’s syndrome, where the adrenal gland secretes exces-
sive amount of glucocorticoid hormone under the stimu-
lation of ACTH overproduction commonly from pitui-
tary tumor or ectopic ACTH production, and ACTH-in-
dependent Cushing’s syndrome which caused by adrenal 
hypersecretion of cortisol, commonly happens in benign 
adrenocortical adenoma2. Cushing’s syndrome, aside 
from the usual signs and symptoms such as Cushingoid 
face and purple striae, can also manifest in neuropsychi-
atric symptoms which can be mistakenly diagnosed as 
another disease. Cushing’s syndrome patients appear to 
manifest, at minimum, the triad of irritability, insomnia, 
and decreased libido and may persist as the disease pro-
gresses3. These neuropsychiatric symptoms should not 
be ignored and need to be explored holistically from 
every aspect in order to establish the right diagnosis. 
 The diagnosis of Cushing’s syndrome can be made 
initially through several tests, for examples Urine Free 
Cortisol (UFC), late-night salivary cortisol, and 
dexamethasone suppression test or DST (overnight 1-mg 
or longer low-dose). Giving a supraphysiological dose of 
exogenous glucocorticoid in healthy population 
suppresses ACTH production that subsequently 
decreases cortisol secretion. Patient with endogenous 
Cushing's syndrome of any reason will fail to achieve 
this suppression when low dose of exogenous 
glucocorticoid is given4,5. Patient with ACTH-dependent 
Cushing's syndrome commonly caused by pituitary 
microadenoma, also known as Cushing's disease, 
overnight 1-mg DST will not suppress the cortisol level 
but it will be suppressed by overnight 8 mg-high dose 
DST6. Decrease of cortisol level by 50% from the base-
line level after the administration overnight 8-mg 
dexamethasone supports the diagnosis of ACTH-
dependent Cushing's syndrome. The failure to reach the 
50% suppression of cortisol level after overnight 8-mg 
DST suggests ACTH-independent Cushing's syndrome 
possibly from adrenal tumors6,7. In this case report, we 
presented a of 30-year-old woman with Cushing’s syn-
drome manifesting as chronic insomnia with pituitary 
microadenoma and adrenal cortical adenoma, conditions 
which could both contribute to Cushing’s syndrome but 
very different in origin cause and later the management. 
 
CASE REPORTS 
 A 30-year-old woman consulted from the Neurologic 
Department to the Internal Medicine Department with a 
chief complaint of insomnia and aggravating headache 
since 6 months prior to the admission. She also had 
difficulty to concentrate and muscle weakness. She 
reported that she gained 5 kg body weigh in a month.  
 
 She had visited some hospitals and doctors before 
and undergone medical check-ups but no abnormality 
was found. She was given sleeping medications but the 
symptoms weren’t improved. She denied any history of 
consumption of over the counter drugs or herbal 
medicines. The physical examination showed she was 
overweight with the BMI of 27,34 kg/m2 and had signs 
of hypercortisolism such as Cushingoid face (Figure 2) 
and reddish-purple striae (Figure 1) on her stomach. The 
vital sign was within the range of hypertension stage 1.  
 She had previously undergone examinations such as 
EEG, polysomnography, head MRI (Figure 5), and ab-
dominal CT scan (Figure 6). EEG examination showed 
diffuse low voltage pattern on both brain hemisphere. 
Polysomnography examination revealed abnormal sleep 
architecture and she couldn’t reach REM phase. Insom-
nia was confirmed with sleep efficiency was only 71%. 
She also had mild OSA (Obstructive Sleep Apnea) with 
AHI (Apnea-Hypopnea Index) 8,7. Oxygen saturation 
was quite low with level of 93% during sleep. A head 
MRI examination revealed a solid lesion on pituitary 
gland suspected of pituitary microadenoma with the 
diameter of 0,2 cm but no sign of increased intracranial 
pressure was found. The abdominal CT-scan revealed a 
solid left adrenal mass with the diameter of 
approximately 2,7 cm. Midnight cortisol serum was ini-
tially performed and showed elevated cortisol serum with 
the level of 19,8 µg/dL (normal level 2,9 – 17,3 µg/dL). 
 The patient had both pituitary microadenoma and left 
adrenal mass that could contribute to the development of 
endogenous Cushing’s syndrome thus high dose dexame-
thasone suppression test (8 mg overnight) was performed 
to distinguish the main cause of Cushing’s syndrome. 
The test resulted the failure to reach 50% suppression of 
serum cortisol from baseline level of 19,8 g/dL to 18,1 
g/dL after the administration of overnight 8-mg 
dexamethasone. This concluded the Cushing’s syndrome 
in the patient was not ACTH-dependent from the pitui-
tary microadenoma and more implicative to the 
overproduction of cortisol by the left adrenal mass. The 
patient underwent left adrenalectomy and was treated 
with intravenous hydrocortisone 100 mg/day before the 
surgery to prevent adrenal insufficiency. 
 Post-adrenalectomy serum cortisol was lower than 
0,8 µg/dL without any sign and symptom of adrenal in-
sufficiency. The intravenous hydrocortisone 100 mg/day 
was continued until 3 days after the surgery and switched 
to oral hydrocortisone 20 mg/day in the morning. Patient 
was discharged from the hospital 7 days after the surgery. 
Oral hydrocortison 20 mg/day in the morning was con-
tinued until 1 month following the surgery. Histological 
analysis of the left adrenal mass showed diffuse cells with 
monotone oval nucleus and no sign of malignancy was 
present. Immunohistochemistry staining profile result 
showed Synaptopshysin was positive, Chromogranin-A 
was negative, NSE was negative, Calretinin was positive, 
and Ki67 was positive in less than 2% around the peri-
nuclear area, supproted the diagnosis of adrenal cortical 
adenoma. The signs and symptoms of hypercortisolism, 
such as Cushingoid face and insomnia, were improved 
within 9 months after the surgery (Figure 3, Figure 4). 
 
DISCUSSION  
 Cortisol is the main glucocorticoid hormone 
produced by the adrenal cortex and very important for 
maintaining most physiological state. The cortisol 
secretion is controlled by illustration of a hypothalamic-
pituitary-adrenal axis (HPA axis). High level of cortisol 
whether caused by the excessive use of exogenous 
glucocorticoids (iatrogenic) or overproduction of endog-
enous cortisol can cause adverse effects on organ 
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The incidence of Cushing’s syndrome is 0,7-2,4 per 
million population per year. ACTH-independent 
Cushing’s syndrome makes up for 15%–20% of 
Cushing’s syndrome in adults; in which 90% are caused 
by unilateral adrenal tumors4,8. 
 Cushing’s syndrome has unique manifestations 
which are quite distinctive, for examples purple striae, 
facial plethora, proximal muscle weakness, easily 
bruising without evident of trauma, and unexplained 
osteoporosis4,9. These manifestations of Cushing’s syn-
drome, though, can be diverse by individuals. The pa-
tient in our case first consulted from Neurologic Depart-
ment with the chief complaint of insomnia and headache. 
She already went to consult with several doctors and 
hospitals before and was only given sleeping medica-
tions but didn’t show any improvement. With thorough 
physical examination she actually showed several signs 
of Cushing’s syndrome such as purple striae, Cushingoid 
face, and muscle weakness, which could allude estab-
lishing the diagnosis. 
Insomnia is a sleep disorder described by problems in 
falling or staying asleep or having restorative sleep ac-
companied by daytime impairment. There are sugges-
tions that HPA axis disturbance and elevation of evening 
cortisol are contributive to the development of insomnia. 
Although there are still limited number of studies, 
changes of polysomnography in Cushing’s syndrome 
have been apparent thus proving the adverse effect of 
high level of glucocorticoid on sleep architecture. The 
changes may include reduction of Slow Wave Sleep or 
SWS, disruption of sleep continuity (increased sleep la-
tency, enhanced waketime) and disturbance in Rapid 
Eye Movement or REM (shortened REM latency, ele-
vated REM density). Oddly enough, these sleep disturb-
ances are indistinguishable from those existing in major 
depression10. 
 Cortisol decreases REM phase in sleep and excessive 
concentrations in blood can cause insomnia and strik-
ingly increase or decrease mood11. Cushing syndrome 
may also present as psychiatric and cognitive disorders 
in up to 70%–85% of the patients. Depression, emotional 
lability, and irritability are the most frequent presenta-
tions; anxiety, panic attacks, acute psychosis, mania, 
paranoia, and suicidal tendencies are uncommon12. Re-
duced in brain volume, especially the hippocampus, has 
been linked to the high level of cortisol, and associated 
with learning disability and short-term memory impair-
ment. This psychiatric and cognitive manifestations may 
improve after remission but many are still persist5,13. 
 Patient suspected of ACTH-dependent Cushing's 
syndrome should be evaluated with a pituitary imaging 
with the MRI. However, ACTH-producing pituitary tu-
mors can be quite hard to be detected even with ad-
vanced MRI methods because they commonly present as 
small lesions14. Furthermore, around 10% of healthy and 
normal population may possess incidental pituitary le-
sions equal to 6 mm in size15. Therefore, diagnosing 
ACTH-dependent Cushing’s syndrome can be quite ar-
duous. Head MRI and abdominal CT-scan results 
showed the patient had pituitary microadenoma and left 
adrenal mass respectively. Both conditions can lead to 
excessive cortisol level which present as Cushing’s syn-



















































Figure 4. The patient’s face 9 months after the left 
adrenalectomy 
 
 Dexamethasone suppression test or DST is one of the 
tests recommended as initial examination for diagnosing 
Cushing’s syndrome. DST works on the principle of glu-
cocorticoid suppressibility in adrenal function through 
the suppression mechanism of ACTH production by the 
pituitary. The test can be done either in overnight 1-mg 
test or longer and lower dose (2 mg/day over 48 hours). 
The overnight 1-mg test is a simple and can be done in 
outpatient setting. One mg dexamethasone is usually 
given around 11 pm, and cortisol level is evaluated be-
tween 8-9 am the following morning. Experts have rec-
ommended a limit for suppression of the post dexame-
thasone serum cortisol to lower than 1,8 µg/dl to attain 
higher sensitivity of more than 95%4,5.  
 
Figure 2. The patient’s face 
before the treatment 
 
Figure 3. The patient’s face 
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Figure 5. Head MRI 
 
 
Figure 6. Abdominal CT-scan 
 
 However patient with ACTH-dependent Cushing's 
syndrome, overnight 1-mg DST will not suppress the 
cortisol level and particularly need higher dose with 
overnight 8 mg high dose DST6,16. Reduced cortisol level 
by 50% from the baseline after the overnight 8 mg high 
dose DST supports the diagnosis of ACTH-dependent 
Cushing's syndrome. The failure to reach the 50% reduc-
tion of cortisol after overnight 8-mg DST suggests 
ACTH-independent Cushing's syndrome which may 
arise from adrenal tumors6,7 
 In this patient, midnight cortisol serum examination 
initially performed and showed high level of cortisol. 
Apparently, from the previously done imaging examina-
tions she was found to have pituitary microadenoma and 
left adrenal mass that could both become the possible 
sources of Cushing’s syndrome. Overnight 8 mg high 
dose DST was later performed to distinguish the main 
cause of Cushing’s syndrome in this patient. The result 
showed failure to reach 50% of decrease of cortisol se-
rum from the baseline. This result implied that the source 
of Cushing’s syndrome was not ACTH-dependent from 
the pituitary microadenoma and possibly ACTH-inde-
pendent from the left adrenal mass. Left adrenalectomy 
was done to remove the source of excessive cortisol level 
and hydrocortisone therapy was given to prevent adrenal 
insufficiency. The histological study and immunohisto-
chemistry staining of the adrenal mass supported the pat-
tern of adrenal cortical adenoma. Her signs and symp-
toms, including the Cushingoid face and the insomnia, 




 Cushing’s syndrome may present as neuropsychiatric 
disorders, as in this case being chronic insomnia, and 
should be explored thoroughly accompanied by adequate 
physical examination to establish the proper diagnosis. 
High dose dexamethasone suppression test (8 mg over-
night) can help distinguishing the main etiology of Cush-
ing’s syndrome in this case where the patient had more 
than one possible source of cortisol overproduction. The 
lack of cortisol suppression after high dose dexame-
thasone administration concluded the source of cortisol 
excess was not ACTH-dependent from the pituitary mi-
croadenoma and indicatory of adrenal etiology. 
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